‘Variant tracking an essential part of long-term strategy’: Satyajit Rath
Satyajit Rath was trained as a physician and a pathologist and has worked on mechanisms involved in the development and functioning of the immune system, in India and overseas, and later as a faculty member at the National Institute of Immunology in New Delhi. There is quite good evidence for SARS-CoV-2 virus that such ‘neutralising’ antibodies do protect better than non-neutralising ones. ‘THE INDIAN VARIANT’ The government took offence to one of the variants being described as an “Indian” variant by sections of the media. That said, ‘I am shocked, shocked, I tell you’, when I see the Press Information Bureau of the Government of India using these very geographical nomenclatures it objects so strongly to for SARS-CoV-2 virus variants: On January 12, 2021, ‘ Total number of persons found positive with UK variant strain of COVID is 96 ’; and on March 24, 2021, ‘ These include 736 samples positive for viruses of the UK lineage. It is also to do with a lack of trust and enthusiasm amongst Indian ‘experts’ from very different domains in order to work efficiently and productively in well-formed collaborations on large scale.

Discover Related

India maps its genes: How GenomeIndia is a step towards personalised medicine

Indian scientists complete sequencing of 10,000 genomes for database

It feels a lot like 2020: What India is doing to avoid a China-like COVID surge

Centre writes to states over rise in Covid-19 cases abroad

From sequencing to surveillance: How India's INSACOG track mutations in Covid-19

Explainer: What is genome sequencing and surveillance? Why is it important?

B.1.617.2 becoming dominant variant in India, finds genome sequencing

Scientists race to study coronavirus variant in India as cases explode

No basis for calling double mutant 'Indian variant', clarify govt and WHO

WHO classifies Covid mutation in India as ’variant of concern’

Variant deepening India’s crisis, says top WHO scientist
